Journal article

Health care costs associated with Australian tertiary inflammatory bowel disease care

Belinda Jackson, Danny Con, Ronald Ma, Alexandra Gorelik, Danny Liew, Peter De Cruz

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | TAYLOR & FRANCIS LTD | Published : 2017

Abstract

INTRODUCTION: We aimed to describe the total costs of illness for IBD patients and compare the costs of patients with active disease to those with inactive disease. MATERIALS AND METHODS: Resource use for IBD management was itemized for attributable costs (AUD) among all IBD patients over a 12-month period at an Australian hospital. RESULTS: One hundred and eighty-three patients were included (87 ulcerative colitis (UC); 93 Crohn's disease (CD); three IBD-unclassified). The median (IQR) annual overall cost was higher in the CD versus UC group ($15,648 versus $5017; p < .001). The difference in cost between CD and UC was influenced by the difference in outpatient costs for CD patients..

View full abstract

Grants

Funding Acknowledgements

The Gutsy Group provided research support. Ferring has provided an unrestricted educational grant, but played no part in study design, analysis, or reporting. B. J. is supported by a National Health and Medical Research Council (NHMRC) and AVANT DiT scholarship. P. D. C is supported by a David Bickart Clinician Research award from the University of Melbourne and a Bushell Postdoctoral award from the Gastroenterological Society of Australia (GESA).